A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)

Clinical trial NCT03062943 · COMPLETED

Trial details

NCT number: NCT03062943
Sponsor: IRCCS Multimedica
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphangioleiomyomatosis

Start date: 2016-12-06
Primary completion: 2021-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.